Workflow
Trevi Therapeutics(TRVI) - 2025 Q2 - Quarterly Results
2025-08-07 20:08
Exhibit 99.1 Trevi Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates Announced positive topline results from its Phase 2b CORAL trial of Haduvio for the treatment of chronic cough in patients with IPF Closed $115 million underwritten offering with expected cash runway into 2029 Management to host a conference call and webcast today at 4:30 p.m. ET New Haven, Conn., August 7, 2025 – Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company deve ...
Eventbrite(EB) - 2025 Q2 - Quarterly Results
2025-08-07 20:08
[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b) (10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed. Execution Version CREDIT AGREEMENT Dated as of August 6, 2025, among EVENTBRITE, INC., as the Borrower, THE GUARANTORS PARTY HERETO FROM TIME TO TIME, SILICON VALLEY BANK, A DIVISION OF FIRST-CITIZENS BANK & TRUST COMPANY, as Administrative Agent and Collateral Agent, THE LENDERS P ...
Janux Therapeutics(JANX) - 2025 Q2 - Quarterly Results
2025-08-07 20:08
Janux Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights SAN DIEGO, August 7, 2025 – Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technologies to its Tumor Activated T Cell Engager (TRACTr), Tumor Activated Immunomodulator (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms, today reported financial results for the second quarter ended J ...
Hannon Armstrong Sustainable Infrastructure Capital(HASI) - 2025 Q2 - Quarterly Results
2025-08-07 20:08
HASI Announces Second Quarter 2025 Results ANNAPOLIS, Md., August 7, 2025 -- (BUSINESS WIRE) -- HA Sustainable Infrastructure Capital, Inc. ("HASI," "We," "Our" or the "Company") (NYSE: HASI), a leading investor in sustainable infrastructure assets, today reported results for the second quarter of 2025. Key Highlights "Our business continues to make strong progress, with closed transactions growing 9% year-over-year in the first half of 2025 and double-digit yields on new Portfolio investments supporting st ...
StepStone (STEP) - 2026 Q1 - Quarterly Results
2025-08-07 20:08
Report Overview and Key Announcements [First Quarter Fiscal 2026 Results Announcement](index=1&type=section&id=First%20Quarter%20Fiscal%202026%20Results%20Announcement) StepStone Group announced Q1 FY2026 results, including a net loss and a **$0.28 per share** quarterly dividend - The Board of Directors declared a quarterly cash dividend of **$0.28 per share** of Class A common stock[1](index=1&type=chunk) - The results cover the first quarter of the fiscal year ending March 31, 2026[1](index=1&type=chunk) [Company Profile](index=1&type=section&id=Company%20Profile) StepStone Group is a global private markets investment firm managing **$723 billion** total capital and **$199 billion** AUM Capital Responsibility as of June 30, 2025 | Metric | Amount (USD) | | :--- | :--- | | Total Capital | ~$723 billion | | Assets Under Management (AUM) | $199 billion | - The firm's clients include large institutional investors like pension funds and sovereign wealth funds, as well as family offices and private wealth clients[4](index=4&type=chunk) - StepStone specializes in private equity, infrastructure, private debt, and real estate asset classes[4](index=4&type=chunk) Financial Performance [Financial Highlights and Key Operating Metrics Summary](index=3&type=section&id=Financial%20Highlights%20and%20Key%20Operating%20Metrics%20Summary) Q1 FY2026 reported a GAAP net loss of **$12.0 million**, with Adjusted Net Income at **$48.5 million** Q1 FY2026 vs Q1 FY2025 GAAP Performance | Metric | Q1 FY2026 (ended Jun 30, 2025) (USD million) | Q1 FY2025 (ended Jun 30, 2024) (USD million) | YoY Change | | :--- | :--- | :--- | :--- | | Total Revenues | 364.3 | 186.4 | +95% | | Net Income (Loss) | (12.0) | 48.0 | N/A | | Diluted EPS | (0.49) | 0.20 | N/A | Q1 FY2026 vs Q1 FY2025 Non-GAAP Performance | Metric | Q1 FY2026 (ended Jun 30, 2025) (USD million) | Q1 FY2025 (ended Jun 30, 2024) (USD million) | YoY Change | | :--- | :--- | :--- | :--- | | Fee Revenues | 212.7 | 178.5 | +19% | | Fee-Related Earnings (FRE) | 81.2 | 71.7 | +13% | | Adjusted Net Income (ANI) | 48.5 | 57.2 | -15% | | ANI Per Share | 0.40 | 0.48 | -17% | Key Business Drivers (as of June 30) | Metric | 2025 (USD billion) | 2024 (USD billion) | YoY Change | | :--- | :--- | :--- | :--- | | Assets Under Management (AUM) | 199.3 | 169.3 | +18% | | Fee-Earning AUM (FEAUM) | 127.2 | 100.4 | +27% | | Assets Under Advisement (AUA) | 524.2 | 531.4 | -1% | [GAAP Condensed Consolidated Financial Statements](index=4&type=section&id=GAAP%20Condensed%20Consolidated%20Financial%20Statements) GAAP financials show total assets at **$4.78 billion**, liabilities at **$3.08 billion**, and a **$12.0 million** net loss [Balance Sheets](index=4&type=section&id=Balance%20Sheets) As of June 30, 2025, total assets were **$4.78 billion**, total liabilities **$3.08 billion**, and stockholders' equity **$1.23 billion** Selected Balance Sheet Items | Account | June 30, 2025 (USD thousands) | March 31, 2025 (USD thousands) | | :--- | :--- | :--- | | **Total Assets** | **4,782,411** | **4,586,693** | | Cash and cash equivalents | 191,469 | 244,791 | | Accrued carried interest allocations | 1,585,209 | 1,495,664 | | **Total Liabilities** | **3,084,999** | **2,812,321** | | Accrued compensation and benefits | 943,007 | 736,695 | | **Total Stockholders' Equity** | **1,230,579** | **1,390,148** | [Statements of Income (Loss)](index=5&type=section&id=Statements%20of%20Income%20(Loss)) Q1 FY2026 total revenues rose to **$364.3 million**, but expenses surged to **$423.3 million**, resulting in a **$12.0 million** net loss Condensed Income Statement | Account | Three Months Ended June 30, 2025 (USD thousands) | Three Months Ended June 30, 2024 (USD thousands) | | :--- | :--- | :--- | | Management and advisory fees, net | 211,173 | 178,015 | | Total performance fees | 153,114 | 8,386 | | **Total revenues** | **364,287** | **186,401** | | Equity-based compensation | 188,718 | 19,179 | | **Total expenses** | **423,316** | **139,250** | | **Net income (loss)** | **(12,011)** | **48,045** | | Net income (loss) attributable to StepStone Group Inc. | (38,424) | 13,328 | Non-GAAP Financial Measures and Reconciliations [Fee Revenues and Adjusted Revenues](index=6&type=section&id=Fee%20Revenues%20and%20Adjusted%20Revenues) Q1 FY2026 fee revenues increased **19%** to **$212.7 million**, with adjusted revenues reaching **$237.5 million** Fee Revenues by Source | Source | Q1 FY2026 (Jun 30, 2025) (USD thousands) | Q1 FY2025 (Jun 30, 2024) (USD thousands) | | :--- | :--- | :--- | | Focused commingled funds | 120,036 | 104,798 | | Separately managed accounts | 70,379 | 57,376 | | Advisory and other services | 19,939 | 14,769 | | **Total Fee Revenues** | **212,740** | **178,514** | - Adjusted revenues are reconciled from total GAAP revenues by excluding unrealized carried interest allocations and other specific items to present a measure of realized revenues[23](index=23&type=chunk)[25](index=25&type=chunk) [Adjusted Net Income (ANI) and Fee-Related Earnings (FRE)](index=7&type=section&id=Adjusted%20Net%20Income%20(ANI)%20and%20Fee-Related%20Earnings%20(FRE)) Q1 FY2026 Adjusted Net Income was **$48.5 million**, Fee-Related Earnings **$81.2 million**, with an FRE margin of **38%** - ANI is a non-GAAP measure of after-tax net realized income used to evaluate profitability, excluding unrealized items, certain equity compensation, and amortization of intangibles[28](index=28&type=chunk) - FRE is a component of ANI used to monitor baseline earnings from recurring management and advisory fees[29](index=29&type=chunk) Reconciliation to ANI and FRE for Q1 FY2026 | Metric | Amount (USD thousands) | | :--- | :--- | | Income (loss) before income tax | (20,350) | | Adjustments (Unrealized items, Equity comp, etc.) | 82,790 | | **Pre-tax ANI** | **62,440** | | Income taxes | (13,906) | | **ANI** | **48,534** | | Adjustments to derive FRE | 18,806 | | **FRE** | **81,246** | - The FRE margin for the quarter ended June 30, 2025 was **38%**, calculated as FRE (**$81.2 million**) divided by Fee Revenues (**$212.7 million**)[44](index=44&type=chunk)[45](index=45&type=chunk) [Performance Fee-Related Earnings (PRE)](index=11&type=section&id=Performance%20Fee-Related%20Earnings%20(PRE)) Q1 FY2026 Performance Fee-Related Earnings (PRE) were **$13.0 million**, a **40% decrease** year-over-year PRE Calculation for Q1 FY2026 | Metric | Amount (USD thousands) | | :--- | :--- | | Gross realized performance fees | 24,727 | | Realized performance fee-related compensation | (11,705) | | **PRE** | **13,022** | - Gross realized performance fees for Q1 FY2026 (**$24.7 million**) decreased by **42%** from Q1 FY2025 (**$42.7 million**)[8](index=8&type=chunk) [Adjusted Net Income (ANI) Per Share](index=12&type=section&id=Adjusted%20Net%20Income%20(ANI)%20Per%20Share) Q1 FY2026 ANI per share was **$0.40**, a **17% decrease** year-over-year, based on **122.3 million** adjusted shares ANI Per Share Calculation for Q1 FY2026 | Metric | Amount | | :--- | :--- | | ANI (USD thousands) | 48,534 | | Adjusted weighted-average shares | 122,292,943 | | **ANI per share (USD)** | **0.40** | - Adjusted weighted-average shares increased by **3%** year-over-year to **122.3 million**[8](index=8&type=chunk) Key Operating Metrics [Fee-Earning AUM (FEAUM)](index=13&type=section&id=Fee-Earning%20AUM%20(FEAUM)) FEAUM grew **27%** year-over-year to **$127.2 billion** as of June 30, 2025, with **$5.0 billion** in quarterly contributions FEAUM Roll-Forward | Metric | Q1 FY2026 (ended Jun 30, 2025) (USD millions) | | :--- | :--- | | Beginning Balance | 121,390 | | Contributions | 5,035 | | Distributions | (1,402) | | Market value, FX and other | 2,196 | | **Ending Balance** | **127,219** | - Contributions to FEAUM for the quarter were **$5.0 billion**, a **35% decrease** from the **$7.7 billion** contributed in the same quarter of the prior year[56](index=56&type=chunk) [Asset Class Summary](index=14&type=section&id=Asset%20Class%20Summary) As of June 30, 2025, total capital responsibility was **$723.5 billion**, AUM **$199.3 billion**, and FEAUM **$127.2 billion** FEAUM by Asset Class (as of June 30, 2025) | Asset Class | FEAUM (USD millions) | YoY Change | | :--- | :--- | :--- | | Private equity | 66,428 | +21% | | Infrastructure | 26,090 | +28% | | Private debt | 21,435 | +33% | | Real estate | 13,266 | +48% | | **Total** | **127,219** | **+27%** | AUM by Asset Class (as of June 30, 2025) | Asset Class | AUM (USD millions) | YoY Change | | :--- | :--- | :--- | | Private equity | 100,540 | +13% | | Infrastructure | 40,087 | +22% | | Private debt | 39,242 | +29% | | Real estate | 19,445 | +15% | | **Total** | **199,314** | **+18%** | - Total capital responsibility, the sum of AUM and AUA, reached **$723.5 billion**, a **3% increase** year-over-year[60](index=60&type=chunk)[61](index=61&type=chunk) Supplementary Information [Legal Disclaimers and Non-GAAP Measures](index=2&type=section&id=Legal%20Disclaimers%20and%20Non-GAAP%20Measures) The report includes forward-looking statements and utilizes non-GAAP financial measures, which supplement but do not substitute GAAP results - The report includes forward-looking statements that are not guarantees of future performance and are subject to various risks and uncertainties[5](index=5&type=chunk) - The company uses several non-GAAP financial measures to supplement its GAAP financial statements, for which definitions and reconciliations are provided within the report[6](index=6&type=chunk) [Glossary of Terms](index=16&type=section&id=Glossary%20of%20Terms) The glossary defines key metrics including AUM, AUA, FEAUM, and total capital responsibility, used throughout the report - AUM: Assets where the firm has full discretion over investment decisions[67](index=67&type=chunk) - AUA: Client assets for which the firm provides advisory or monitoring services without full discretion[65](index=65&type=chunk) - FEAUM: Assets from which the company earns management fee revenue, typically based on capital commitments or net invested capital[70](index=70&type=chunk)
Evercore(EVR) - 2025 Q2 - Quarterly Report
2025-08-07 20:08
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q _____________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 001-32975 _________________________________________________ ...
First Bank(FBNC) - 2025 Q2 - Quarterly Report
2025-08-07 20:08
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 Commission File Number 0-15572 FIRST BANCORP (Exact Name of Registrant as Specified in its Charter) | North Carolina | | | 56-1421916 | | --- | --- | --- | --- | | (State or Other Jurisdiction of Incorporation or Organization) | | | (I.R.S. Employer Identification Number) | | 300 SW Broad St., | Southern Pines , | North Carolina | 28387 | | (Address of Principal Executive Offi ...
SenesTech(SNES) - 2025 Q2 - Quarterly Results
2025-08-07 20:08
Balance Sheet Highlights • Current cash balance as of August 5, 2025 is $11.2 million — This provides us with an operating runway through the end of 2027 and beyond, based on the most recent quarterly run rate. Exhibit 99.1 SenesTech Reports Second Quarter 2025 Financial Results with Record Revenue and Record Gross Profit Margins 94% Revenue Growth in Evolve Rodent Birth Control Products TM Strong Cash Balance and Sustained Progress Toward Profitability SURPRISE, Ariz., August 7, 2025 /PRNewswire/ — SenesTe ...
Apyx Medical(APYX) - 2025 Q2 - Quarterly Report
2025-08-07 20:08
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number: 001-31885 APYX MEDICAL CORPORATION (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ...
Fidus Investment (FDUS) - 2025 Q2 - Quarterly Results
2025-08-07 20:08
Exhibit 99.1 FIDUS INVESTMENT CORPORATION ANNOUNCES SECOND QUARTER 2025 FINANCIAL RESULTS Board of Directors Declared Total Dividends of $0.57 per Share for Third Quarter 2025 Base Dividend of $0.43 and Supplemental Dividend of $0.14 Per Share EVANSTON, Ill., August 7, 2025 – Fidus Investment Corporation (NASDAQ:FDUS) ("Fidus" or the "Company"), a provider of customized debt and equity financing solutions, primarily to lower middle-market companies based in the United States, today announced its financial r ...